Insider Buying: Cosmos Health (NASDAQ:COSM) CEO Purchases 124,880 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 124,880 shares of the business’s stock in a transaction on Wednesday, January 7th. The stock was acquired at an average price of $0.52 per share, with a total value of $64,937.60. Following the transaction, the chief executive officer directly owned 6,975,604 shares of the company’s stock, valued at $3,627,314.08. This represents a 1.82% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The shares were bought at an average cost of $0.54 per share, for a total transaction of $72,334.62.
• On Friday, December 19th, Grigorios Siokas bought 88,314 shares of Cosmos Health stock. The stock was bought at an average cost of $0.49 per share, with a total value of $43,273.86.
• On Monday, December 15th, Grigorios Siokas purchased 168,472 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.42 per share, for a total transaction of $70,758.24.
• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas purchased 55,732 shares of Cosmos Health stock. The stock was purchased at an average price of $0.63 per share, with a total value of $35,111.16.
• On Friday, November 21st, Grigorios Siokas acquired 56,080 shares of Cosmos Health stock. The shares were bought at an average price of $0.68 per share, with a total value of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas bought 51,315 shares of Cosmos Health stock. The shares were bought at an average price of $0.62 per share, for a total transaction of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas purchased 61,614 shares of Cosmos Health stock. The shares were purchased at an average price of $0.65 per share, with a total value of $40,049.10.

Cosmos Health Trading Up 0.9%

Shares of Cosmos Health stock traded up $0.00 during trading hours on Thursday, reaching $0.53. 279,560 shares of the company’s stock were exchanged, compared to its average volume of 361,248. The company has a fifty day moving average of $0.59 and a 200-day moving average of $0.73. Cosmos Health Inc. has a 52-week low of $0.28 and a 52-week high of $1.32. The firm has a market capitalization of $19.65 million, a price-to-earnings ratio of -0.70 and a beta of 5.37. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings data on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.16). The company had revenue of $17.11 million for the quarter, compared to analysts’ expectations of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. Sell-side analysts forecast that Cosmos Health Inc. will post -0.78 EPS for the current fiscal year.

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC grew its holdings in Cosmos Health Inc. (NASDAQ:COSM) by 133.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 225,507 shares of the company’s stock after purchasing an additional 128,776 shares during the quarter. Citadel Advisors LLC owned about 0.65% of Cosmos Health worth $250,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 12.61% of the company’s stock.

Analyst Upgrades and Downgrades

COSM has been the topic of a number of analyst reports. Wall Street Zen raised shares of Cosmos Health to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings restated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.